Respiratory Syncytial Virus (RSV) is the most common cause of bronchiolitis and pneumonia in infants less than 1 year of age, and has been recognized as an important cause of respiratory illness in adults¹. There is no vaccine for RSV, and previous exposure does not provide complete immunity against re-exposure.

ATCC now offers a high-titer, sucrose-cushion purified RSV A-2 strain (ATCC® VR-1540P™) for use in RSV research. Each ampoule contains 200µL of purified virus at a concentration >2 x 10⁸ PFU/mL, and is useful in a variety of applications where high titer material is required, such as challenge studies and viral clearance assays.

To request custom high-titer, purified virus from other ATCC viral cultures, please contact us at atccbioservices@atcc.org.

References ¹ Respiratory Syncytial Virus (RSV): Incidence and Infection. CDC. Available on the web at www.cdc.gov/rsv/about/infection.html.